• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度的黑真菌爆发——新冠疫情激增的直接后果:是谣言还是事实。

Black fungus outbreak in India - A direct consequence of COVID-19 surge: A myth or reality.

作者信息

Sharma Archana, Bedi Megha, Patel Prachi, Singh Arora Amarpreet

机构信息

Department of Environmental Science and Engineering, Marwadi University, Rajkot 36004, Gujarat, India.

Department of Civil and Environmental Engineering, University of Pittsburgh, Pittsburgh 15261, PA, USA.

出版信息

Gondwana Res. 2023 Feb;114:117-123. doi: 10.1016/j.gr.2021.12.016. Epub 2022 Feb 5.

DOI:10.1016/j.gr.2021.12.016
PMID:35153531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8816797/
Abstract

The deadly second wave of COVID-19 has seen an unprecedented surge in mucormycosis associated mortality in India, overwhelming the heath authorities with challenges beyond measure. Also known as black fungus, this life-threatening fungal infection usually manifests in the nose, spreads to the eyes, and in some cases also to the brain. Immune suppression, pre-existing conditions, prolonged and indiscriminate use of steroids, and unhygienic environments are some of the widely recognized risk factors for contracting black fungus in individuals recovered from COVID-19. However, diagnosis of the infection remains insufficient due to the lack a holistic understanding of the possible risks, symptoms, and exposure pathways and therefore no definite protocol exists for managing this fatal infection. Here, we synthesize the current state of knowledge on black fungus outbreak in India and identify key gaps in its understanding with respect to potential risk factors leading to the widespread infection. We looked at 3354 black fungus cases in India, enlisting ailment history (particularly diabetes) and steroid usage in COVID-19 patients as the key factors responsible for exacerbating risks associated with the disease. However, we also press on the possibilities that other less studied non-traditional risk factors may also have a role in causing the infection. Black fungus is therefore a reality of COVID-19, with or without diabetes or steroid use needs to be investigated. We believe such a review is imperative for making informed decisions specially around timely diagnosis and channelizing efforts in controlling the spread of COVID-19 associated mucormycosis.

摘要

在新冠疫情致命的第二波中,印度毛霉菌病相关死亡率出现前所未有的激增,给卫生当局带来了难以估量的挑战。这种危及生命的真菌感染也被称为黑真菌,通常在鼻子中出现,扩散到眼睛,在某些情况下还会扩散到大脑。免疫抑制、既有疾病、长期无差别使用类固醇以及不卫生的环境是从新冠中康复的个体感染黑真菌的一些广泛认可的风险因素。然而,由于缺乏对可能的风险、症状和传播途径的全面了解,对该感染的诊断仍然不足,因此不存在管理这种致命感染的明确方案。在此,我们综合了印度黑真菌爆发的当前知识状态,并确定了在对导致广泛感染的潜在风险因素的理解方面的关键差距。我们研究了印度的3354例黑真菌病例,将疾病史(特别是糖尿病)和新冠患者中类固醇的使用列为加剧与该疾病相关风险的关键因素。然而,我们也强调其他研究较少的非传统风险因素也可能在导致感染方面起作用的可能性。因此,无论是否有糖尿病或使用类固醇,黑真菌都是新冠疫情的一个现实情况,需要进行调查。我们认为这样的综述对于做出明智的决策至关重要,特别是在及时诊断以及引导控制新冠相关毛霉菌病传播的努力方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/3e8d2c823595/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/f441b9701cef/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/bc4814557609/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/f6882647d2f0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/5ae0b345930d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/306ae2084e1c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/4ca37156534d/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/3e8d2c823595/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/f441b9701cef/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/bc4814557609/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/f6882647d2f0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/5ae0b345930d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/306ae2084e1c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/4ca37156534d/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8816797/3e8d2c823595/gr6_lrg.jpg

相似文献

1
Black fungus outbreak in India - A direct consequence of COVID-19 surge: A myth or reality.印度的黑真菌爆发——新冠疫情激增的直接后果:是谣言还是事实。
Gondwana Res. 2023 Feb;114:117-123. doi: 10.1016/j.gr.2021.12.016. Epub 2022 Feb 5.
2
Mucormycosis, past and present: a comprehensive review.毛霉病:过去与现在——全面综述
Future Microbiol. 2023 Feb;18:217-234. doi: 10.2217/fmb-2022-0141. Epub 2023 Mar 27.
3
Mucormycosis in COVID-19 pandemic: Risk factors and linkages.2019冠状病毒病大流行中的毛霉病:危险因素及关联
Curr Res Microb Sci. 2021 Dec;2:100057. doi: 10.1016/j.crmicr.2021.100057. Epub 2021 Aug 8.
4
Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.纳米颗粒对与 COVID-19 相关的黑曲霉的抗真菌作用:对生物医学应用的展望。
Int J Mol Sci. 2022 Oct 19;23(20):12526. doi: 10.3390/ijms232012526.
5
Is Mucormycosis an inevitable complication of Covid-19 in India?印度的 COVID-19 是否会不可避免地引发毛霉菌病?
Braz J Infect Dis. 2021 May-Jun;25(3):101597. doi: 10.1016/j.bjid.2021.101597. Epub 2021 Jul 5.
6
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征:印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
7
Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.毛霉病(黑霉病)的流行病学、危险因素、诊断和治疗:综述。
Curr Pharm Biotechnol. 2023;24(13):1645-1656. doi: 10.2174/1389201024666230320111644.
8
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.印度 COVID-19 相关毛霉菌病(CAM):一个严峻的挑战。
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098. doi: 10.1016/j.bjoms.2021.06.013. Epub 2021 Jun 29.
9
Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.导致印度 COVID 相关毛霉菌病爆发的五个可能因素。
Int J Infect Dis. 2021 Nov;112:278-280. doi: 10.1016/j.ijid.2021.09.057. Epub 2021 Sep 27.
10
Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics.印度 COVID-19 大流行期间新生毛霉病病例:抗生素滥用。
Drug Dev Res. 2021 Nov;82(7):880-882. doi: 10.1002/ddr.21862. Epub 2021 Jul 29.

引用本文的文献

1
Air pollution in five Indian megacities during the Christmas and New Year celebration amidst COVID-19 pandemic.在新冠疫情期间,印度五个特大城市在圣诞节和新年庆祝活动期间的空气污染情况。
Stoch Environ Res Risk Assess. 2022;36(11):3653-3683. doi: 10.1007/s00477-022-02214-1. Epub 2022 Apr 2.

本文引用的文献

1
Lockdown during COVID-19 pandemic: A case study from Indian cities shows insignificant effects on persistent property of urban air quality.新冠疫情期间的封锁:一项来自印度城市的案例研究表明,其对城市空气质量持久性的影响微不足道。
Geosci Front. 2022 Nov;13(6):101284. doi: 10.1016/j.gsf.2021.101284. Epub 2021 Aug 12.
2
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India.在印度拦截毛霉菌病、糖尿病和新冠肺炎这一致命三联症。
Postgrad Med J. 2022 Mar 1;98(e2):e108-e109. doi: 10.1136/postgradmedj-2021-140537.
3
Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
导致印度 COVID 相关毛霉菌病爆发的五个可能因素。
Int J Infect Dis. 2021 Nov;112:278-280. doi: 10.1016/j.ijid.2021.09.057. Epub 2021 Sep 27.
4
COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.COVID 相关毛霉菌病:德里一家专门的 COVID 医院的初步研究。
Am J Otolaryngol. 2022 Jan-Feb;43(1):103220. doi: 10.1016/j.amjoto.2021.103220. Epub 2021 Sep 11.
5
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.印度 COVID-19 相关毛霉菌病(CAM):一个严峻的挑战。
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098. doi: 10.1016/j.bjoms.2021.06.013. Epub 2021 Jun 29.
6
The mucormycosis epidemic within COVID-19 pandemic- lessons from India.新冠疫情期间的毛霉病流行——来自印度的经验教训
Brain Behav Immun. 2021 Oct;97:4-5. doi: 10.1016/j.bbi.2021.08.005. Epub 2021 Aug 8.
7
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series.印度一家三级护理医院的冠状病毒病相关毛霉菌病:病例系列
Cureus. 2021 Jul 3;13(7):e16152. doi: 10.7759/cureus.16152. eCollection 2021 Jul.
8
Mucormycosis and COVID-19: An epidemic within a pandemic in India.毛霉菌病与 COVID-19:印度大流行中的一场流行病。
Mycoses. 2021 Oct;64(10):1253-1260. doi: 10.1111/myc.13353. Epub 2021 Jul 24.
9
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
10
Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.COVID-19 感染期间使用类固醇与高血糖——医生应该知道的。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102167. doi: 10.1016/j.dsx.2021.06.004. Epub 2021 Jun 10.